COSM
Cosmos Health Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Cosmos Health Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
—
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Apr 15 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Apr 15 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.
Same SIC code · 6
Same SEC industry code: McKesson Corp, Cardinal Health Inc, Cencora, Inc. and 3 more; no measured co-movers for Cosmos Health Inc..
Same SIC code · 6
Same SEC industry code: McKesson Corp, Cardinal Health Inc, Cencora, Inc. and 3 more; no measured co-movers for Cosmos Health Inc..
No thesis.
Cosmos Health Inc.
0.33
+0.02 · +7.20%
post 0.32 −2.58%
| Manager | Value | % base | |
|---|---|---|---|
| UBS | $109,975 | 25.63% | +4568.31% |
| Vanguard Fiduciary Trustindex-like | $61,761 | 14.39% | +248.71% |
| Jane Street | $53,431 | 12.45% | new |
| Geodeindex-like | $52,110 | 12.14% | −11.32% |
| BlackRockindex-like | $49,462 | 11.53% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| UBS | $109,975 | 25.63% | +4568.31% |
| Vanguard Fiduciary Trustindex-like | $61,761 | 14.39% | +248.71% |
| Jane Street | $53,431 | 12.45% | new |
| Geodeindex-like | $52,110 | 12.14% | −11.32% |
| BlackRockindex-like | $49,462 | 11.53% | 0.00% |
+58.73%
shares held · 10 largest managers
Expected move
No implied move.